Susquehanna International Group’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $43.2K | Sell |
|
|||||
|
2024
Q4 | $449K | Buy |
|
|||||
|
2024
Q3 | $251K | Sell |
|
|||||
|
2024
Q2 | $385K | Buy |
|
|||||
|
2024
Q1 | $116K | Sell |
|
|||||
|
2023
Q4 | $68K | Sell |
|
|||||
|
2023
Q3 | $185K | Buy |
|
|||||
|
2023
Q2 | $159K | Sell |
|
|||||
|
2023
Q1 | $1.15M | Buy |
|
|||||
|
2022
Q4 | $868K | Sell |
|
|||||
|
2022
Q3 | $2.14M | Buy |
|
|||||
|
2022
Q2 | $1.27M | Buy |
|
|||||
|
2022
Q1 | $2.07M | Sell |
|
|||||
|
2021
Q4 | $3.88M | Buy |
|
|||||
|
2021
Q3 | $3.15M | Buy |
|
|||||
|
2021
Q2 | $3.33M | Buy |
|
|||||
|
2021
Q1 | $3.21M | Sell |
|
|||||
|
2020
Q4 | $6.21M | Buy |
|
|||||
|
2020
Q3 | $3.37M | Sell |
|
|||||
|
2020
Q2 | $10.5M | Buy |
|
|||||
|
2020
Q1 | $2.11M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $524K | Sell |
|
|||||
|
2019
Q2 | $373K | Sell |
|
|||||
|
2019
Q1 | $3.26M | Buy |
|
|||||
|
2018
Q4 | $622K | Buy |
|
|||||
|
2018
Q3 | – | Hold |
|
|||||
|
2018
Q2 | – | Hold |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $456K | Sell |
|
|||||
|
2017
Q3 | $615K | Buy |
|
|||||
|
2017
Q2 | $248K | Buy |
|
|||||
|
2017
Q1 | $334K | Sell |
|
|||||
|
2016
Q4 | $362K | Buy |
|
|||||
|
2016
Q3 | $147K | Sell |
|
|||||
|
2016
Q2 | $136K | Buy |
|
|||||
|
2016
Q1 | $160K | Sell |
|
|||||
|
2015
Q4 | $420K | Sell |
|
|||||
|
2015
Q3 | $713K | Buy |
|
|||||
|
2015
Q2 | $946K | Sell |
|
|||||
|
2015
Q1 | $1.34M | Buy |
|
|||||
|
2014
Q4 | $544K | Buy |
|
|||||
|
2014
Q3 | – | Hold |
|